Press Releases

Press Releases

Company establishes two business units with goal of accelerating the advancement of its Radiopharmaceuticals Platform and optimizing the commercial potential of DANYELZA Preliminary Part A data from GD2-SADA Phase 1 trial   demonstrates tolerability and validity of SADA PRIT platform pre-targeting
Jan 10, 2025
Displaying 11 - 12 of 12